AbbVie vet John Leonard moves up to the helm at CRISPR/Cas9 pioneer Intellia, focused on looming human studies
John Leonard, the former top scientist at AbbVie and founding chief medical officer at CRISPR/Cas9 player Intellia Therapeutics, is being kicked up to the CEO …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.